BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Nevada Opioid Center of Excellence (NOCE) - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Nevada Opioid Center of Excellence (NOCE)
X-ORIGINAL-URL:https://nvopioidcoe.org
X-WR-CALDESC:Events for The Nevada Opioid Center of Excellence (NOCE)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20261028T090000
DTEND;TZID=America/Los_Angeles:20261028T103000
DTSTAMP:20260831T231027Z
CREATED:20260831T231027Z
LAST-MODIFIED:20260831T231027Z
UID:23652-1793178000-1793183400@nvopioidcoe.org
SUMMARY:Prenatal Substance Exposure: Kratom\, Maternal Screening\, and Neonatal Abstinence Syndrome
DESCRIPTION:Substance use during pregnancy can affect both the mother and baby. This presentation will focus on prenatal substance exposure\, with special attention to kratom and its possible effects on newborns. We will discuss how to screen pregnant women for substance use in a supportive and nonjudgmental way\, as well as the importance of identifying substance exposure during pregnancy. The presentation will also cover neonatal abstinence syndrome (NAS)\, including common signs of withdrawal in newborns and how these babies can be assessed and cared for. \nLearning Objectives: \nBy the end of this presentation\, participants will be able to: \n\nDescribe the potential maternal and neonatal effects of prenatal substance exposure\, with an emphasis on kratom use during pregnancy.\nIdentify effective and nonjudgmental approaches to screening pregnant women for substance use\, including considerations for identifying kratom exposure.\nRecognize clinical signs of neonatal abstinence syndrome (NAS) and discuss appropriate assessment and management considerations for newborns with prenatal substance exposure.\n\nPresented by: Jennifer Sleiter ARNP\, CPNP\, PMHS \nJennifer Sleiter has worked at the Regional Child Protection Center/STAR Center at Blank Children’s Hospital in Des Moines\, Iowa since 2004. She has worked as a Pediatric Nurse since 1995 and as a Certified Pediatric Nurse Practitioner since 2001. At the STAR Center\, she assesses and treats children that are dealing with issues of abuse and neglect. She also cares for Drug Endangered Children\, including babies that were exposed to substances through their mother’s use during pregnancy and children who have been environmentally exposed due to their caregiver’s use. She is also a member of the Polk County\, Jasper County and state Drug Endangered Children Alliances. Jennifer has extensive community involvement serving as one of the medical representatives on local multidisciplinary teams reviewing child sexual and physical abuse cases\, DEC cases and general case consultation. She is a Certified Pediatric SANE Nurse. She is also certified as a Pediatric Primary Care Mental Health Specialist. In 2012 she received the National Alliance for Drug Endangered Children’s Collaborative Leadership Award\, in 2013 she was named one of the 100 Great Iowa Nurses\, and in 2026 she received the Blank Children’s Hospital Advanced Practice Provider STAR Award. \nContinuing Education Units: 1.5 CEUs\nThis training is approved for continuing education by the boards listed here. \nFunding for this activity was made possible in whole or in part by the Nevada Department of Health and Human Services (DHHS) Director’s Office through the Fund for a Resilient Nevada\, established in Nevada Revised Statutes 433.712 through 433.744. The opinions\, findings\, conclusions\, and recommendations expressed in our courses are those of the author(s) and do not necessarily represent the official views of the Nevada Opioid Center of Excellence or its funders.
URL:https://nvopioidcoe.org/event/prenatal-substance-exposure-kratom-maternal-screening-and-neonatal-abstinence-syndrome/
LOCATION:Zoom Webinar
ATTACH;FMTTYPE=image/jpeg:https://nvopioidcoe.org/wp-content/uploads/2026/08/GettyImages-1211877746.jpg
ORGANIZER;CN="Nevada Opioid Center of Excellence":MAILTO:noce@casat.org
END:VEVENT
END:VCALENDAR